Co-Diagnostics, Inc. (CODX)
Chart Events
Performance Outlook
| Previous Close | 4.5400 |
| Open | 4.5200 |
| Bid | 4.8000 x 1000 |
| Ask | 4.8100 x 1400 |
| Day's Range | 4.5200 - 4.8100 |
| 52 Week Range | 3.6600 - 11.8200 |
| Volume | |
| Avg. Volume | 344,073 |
| Market Cap | 160.762M |
| Beta (5Y Monthly) | -1.14 |
| PE Ratio (TTM) | 3.61 |
| EPS (TTM) | 1.3120 |
| Earnings Date | Aug 10, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.33 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for CODX
Related Research
- Co-Diagnostics, Inc.Weekly Stock ListESG StocksRatingFair ValueEconomic Moat2 days agoArgus Research
- PR Newswire
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 Global Investment Conference on May 23-26
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be presenting at the H.C. Wainwright & Co. 2022 Global Investment Conference, being held in-person and virtually on May 23-26 in Miami, Florida.
- PR Newswire
Co-Diagnostics Reports Solid First Quarter 2022 Financial Results
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the first quarter ended March 31, 2022.
- Simply Wall St.
Investors in Co-Diagnostics (NASDAQ:CODX) have made a stellar return of 289% over the past three years
Co-Diagnostics, Inc. ( NASDAQ:CODX ) shareholders might understandably be very concerned that the share price has...
